Archives

by in
Entry Author Date Location
Some Bold Baseball and Biotech Picks for the 2013 Season 03/11/13 National
Genentech, ImmunoGen Win FDA OK for Souped-Up Breast Cancer Drug 02/22/13 San Francisco
Blaze Bioscience Caps Off $8.5M Financing, Charges Toward Clinic 02/22/13 Seattle
Seattle Genetics Gets $138M in First-Year Sales of Cancer Drug 02/12/13 Seattle
Seattle Genetics, Millennium Cancer Drug Cleared in EU 10/31/12 Seattle
Seattle Genetics Gets $25M in Broader Abbott Deal 10/23/12 Seattle
Seattle Genetics Gets $34.7M in Second-Quarter Sales of Cancer Drug 08/08/12 Seattle
Seattle Genetics, Millennium Get EU Recommendation for Lymphoma Drug 07/20/12 Seattle
Life Science Innovation NW Notes: SeaGen, NanoString, Viket, & More 07/12/12 Seattle
NanoString Nabs Ex-Seattle Genetics Exec to Lead Diagnostic Push 05/29/12 Seattle
Seattle Genetics Follows the Science, Taking on Rare Lymphoma No. 3 05/23/12 Seattle
Targeted Cancer Drugs With Punch: The Next Big Class of Antibodies 05/16/12 National
Seattle Genetics Misses 1st Quarter Sales Estimate, But Sees $1B Future 05/08/12 Seattle
Seattle Genetics Digs Deeper Into the Proverbial Haystack 03/13/12 National
Seattle Genetics Gets New Commercial Boss for Early Days of Adcetris 02/23/12 Seattle
Seattle Genetics, Millennium Look to Broaden Reach of Hodgkin’s Drug 12/09/11 Seattle
Seattle Genetics Beats Expectations With $10M Sales in Lymphoma Drug Debut 11/03/11 Seattle
TEDMED Walking, FDA Clears Pacira Drug, Zogenix Close to NDA, & More San Diego Life Sciences News 11/03/11 San Diego
The Cancer Drug Dark Ages Are Coming to an End 10/31/11 National
Analyst: Seattle Genetics on Pace to Smash Wall Street Forecast with Lymphoma Drug Rollout 10/20/11 Seattle
Seattle Genetics’ Market Debut, Pathway Gets Bought, Theraclone’s Latest Trick Against HIV, & More Seattle-Area Life Sciences News 08/25/11 Seattle
Video: Seattle Genetics CEO Makes the Case for a $100K Cancer Drug 08/22/11 Seattle
Seattle Genetics Sets Lymphoma Drug Price at $13,500 Per Dose 08/22/11 Seattle
Seattle Genetics: The Next Litmus Test for High Priced Cancer Drugs 08/22/11 National
Seattle Genetics Wins FDA Approval of First Drug, a New Treatment for Lymphomas 08/19/11 Seattle
SeaGen Passes FDA Panel, Ken Stuart’s Journey to Seattle Biomed, the Latest M&A Obsession, & More Seattle-Area Life Sciences News 07/21/11 Seattle
Stop the M&A Obsession: Biotech Needs More Companies to Stay Independent 07/18/11 National
Seattle Genetics Lymphoma Drug Gets Second Green Light from FDA Panel 07/14/11 Seattle
Seattle Genetics Wins Unanimous OK for Lymphoma Drug from FDA Panel 07/14/11 Seattle
SeaGen’s Big Day at the FDA, Hutch Nabs $20M HIV Grant, Allozyne’s Nasdaq Plan, & More Seattle-Area Life Sciences News 07/14/11 Seattle
Page 1 of 2 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. Do You Need an Extended Warranty? Do the Math, Says SquareTrade

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.